Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

For better result, minimum character length is four(4)
Results 1 - 10 of 54 for tpi. (0.05 seconds)

CBT 200 Drops 13 Points. More details...
Company Offers EPO Clone To Chinese Market. More details...
3SBio Inc. joined the parade of China biopharmas...
3SBio, Inc. (NSDQ: SSRX) has signed a...
In seventeen months, 3SBio has gone from a well-received...
3SBio Inc. reported that Q2 revenue increased 38% to 60...
Tianyin Pharmaceutical, which specializes in modernized...
Tianyin Pharmaceutical Co. released very positive...
China Biologic Products gained control of a...
Tianyin Pharmaceutical announced that it would spend $3...
prev | 1 | 2 | 3 | 4 | 5 | 6 | next
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital